Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase
Clinical trial NCT00220389 · COMPLETED
Trial details
- NCT number
- NCT00220389
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2007-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.